Biblio Discovery — Demo Discovery Service

25 hasil untuk "Benoit Blanchet"

Menampilkan 1–20 · 0,39 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma

    Aurélien Millet; Nihel Khoudour; Dorothée Lebert dkk.

    Molecules, Vol. 26 No. 5 · 2021 · Inggris · DOAJ Scopus

    Rituximab is a chimeric immunoglobulin G1-kappa (IgG1κ) antibody targeting the CD20 antigen on B-lymphocytes. Its applications are various, such as for the treatment of chronic lymphoid leukemia or non-Hodgkin’s lymphoma in oncology, and it can also be used in the treatment of certain autoimmune…

  2. Artikel Jurnal Teks lengkap

    Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa

    Aurélien Millet; Nihel Khoudour; Jérôme Guitton dkk.

    Biomedicines, Vol. 9 No. 6 · 2021 · Inggris · DOAJ Scopus

    Pembrolizumab is a humanized immunoglobulin G4-kappa anti-PD1 antibody used in the treatment of different solid tumors or haematological malignancies. A liquid chromatography coupled with a high resolution mass spectrometry (orbitrap technology) method was fully developed, optimized, and validated…

  3. Artikel Jurnal Teks lengkap

    Long Term Pharmacological Perturbation of Autophagy in Mice: Are HCQ Injections a Relevant Choice?

    Jean-Daniel Masson; Benoit Blanchet; Baptiste Periou dkk.

    Biomedicines, Vol. 8 No. 3 · 2020 · Inggris · DOAJ Scopus

    Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved catabolic process whose loss-of-function has been linked to a growing list of pathologies. Knockout mouse models of key autophagy genes have been instrumental in the demonstration of the critical functions of…

  4. Artikel Jurnal

    Gut microbiota and host genetics contribute to the phenotypic variation of digestive and feed efficiency traits in growing pigs fed a conventional and a high fiber diet

    Vanille Déru; Francesco Tiezzi; Céline Carillier-Jacquin dkk.

    Genetics Selection Evolution, Vol. 54 No. 1 · 2022 · Prancis · DOAJ Scopus

    Abstract Background Breeding pigs that can efficiently digest alternative diets with increased fiber content is a viable strategy to mitigate the feed cost in pig production. This study aimed at determining the contribution of the gut microbiota and host genetics to the phenotypic variability of…

  5. Artikel Jurnal

    The potential of microbiota information to better predict efficiency traits in growing pigs fed a conventional and a high-fiber diet

    Vanille Déru; Francesco Tiezzi; Céline Carillier-Jacquin dkk.

    Genetics Selection Evolution, Vol. 56 No. 1 · 2024 · Prancis · DOAJ Scopus

    Abstract Background Improving pigs’ ability to digest diets with an increased dietary fiber content is a lever to improve feed efficiency and limit feed costs in pig production. The aim of this study was to determine whether information on the gut microbiota and host genetics can contribute to…

  6. Artikel Jurnal Teks lengkap

    Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib

    Romain Coriat; Hervé Gouya; Olivier Mir dkk.

    PLoS ONE, Vol. 6 No. 2 · 2011 · Inggris · PLOS Scopus

    Portal hypertension, the most important complication with cirrhosis of the liver, is a serious disease. Sorafenib, a tyrosine kinase inhibitor is validated in advanced hepatocellular carcinoma. Because angiogenesis is a pathological hallmark of portal hypertension, the goal of our study was to…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal Teks lengkap

    Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation

    Lauren Bourke; James McCormick; Valerie Taylor dkk.

    PLOS ONE, Vol. 10 No. 12 · 2015 · Inggris · PLOS Scopus

    An increasing number of investigations including human studies demonstrate that pharmacological ischaemic preconditioning is a viable way to protect the heart from myocardial ischaemia/reperfusion (I/R) injury. This study investigated the role of hydroxychloroquine (HCQ) in the heart during I/R…

    Juga tersedia di: DOAJ

  8. Artikel Jurnal Teks lengkap

    Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

    Olivier Mir; Romain Coriat; Benoit Blanchet dkk.

    PLoS ONE, Vol. 7 No. 5 · 2012 · Inggris · PLOS Scopus

    Background: Sorafenib induces frequent dose limiting toxicities (DLT) in patients with advanced hepatocellular carcinoma (HCC). Sarcopenia has been associated with poor performance status and shortened survival in cancer patients. Patients and Methods: The characteristics of Child Pugh A cirrhotic…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal Teks lengkap

    Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study

    Clémence Marin; Nihel Khoudour; Aurélien Millet dkk.

    Pharmaceuticals, Vol. 14 No. 8 · 2021 · Inggris · DOAJ Scopus

    Background: Different liquid chromatography tandem mass spectrometry (LC–MS/MS) methods have been published for quantification of monoclonal antibodies (mAbs) in plasma but thus far none allowed the simultaneous quantification of several mAbs, including immune checkpoint inhibitors. We developed…

  10. Artikel Jurnal

    Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patientsResearch in context

    Blaise Pasquiers; Benoit Blanchet; Xavier Puéchal dkk.

    EBioMedicine, Vol. 121 · 2025 · Inggris · DOAJ Scopus

    Summary: Background: We aimed to provide pharmacokinetic-pharmacodynamic (PK/PD) rationale for selecting the optimal induction and maintenance dosing regimens in ANCA-associated vasculitis (AAV) using a population modelling approach based on PK, ANCA, and gammaglobulins data from a real-world…

  11. Artikel Jurnal Teks lengkap

    Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK 2 -PD) relationship of tacrolimus in liver transplant recipients

    Camille Tron; Jean-Baptiste Woillard; Pauline Houssel-Debry dkk.

    PLOS ONE, Vol. 15 No. 3 · 2020 · Inggris · PLOS Scopus

    Tacrolimus (TAC) is the cornerstone of immunosuppressive therapy in liver transplantation. This study aimed at elucidating the interplay between pharmacogenetic determinants of TAC whole blood and intracellular exposures as well as the pharmacokinetic-pharmacodynamic relationship of TAC in both…

    Juga tersedia di: DOAJ

  12. Artikel Jurnal Teks lengkap

    Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

    Pascaline Boudou-Rouquette; Céline Narjoz; Jean Louis Golmard dkk.

    Public Library of Science · 2012 · Inggris · PLOS Scopus

    Background: Identifying predictive biomarkers of drug response is of key importance to improve therapy management and drug selection in cancer therapy. To date, the influence of drug exposure and pharmacogenetic variants on sorafenib-induced toxicity remains poorly documented. The aim of this…

    Juga tersedia di: DOAJ

  13. Artikel Jurnal Teks lengkap

    Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients

    Marie-Sophie Minot-This; Pascaline Boudou-Rouquette; Anne Jouinot dkk.

    Pharmaceutics, Vol. 14 No. 6 · 2022 · Inggris · DOAJ Scopus

    Background: Pazopanib (PAZ) is an oral angiogenesis inhibitor approved to treat soft tissue sarcoma (STS) but associated with a large interpatient pharmacokinetic (PK) variability and narrow therapeutic index. We aimed to define the specific threshold of PAZ trough concentration (Cmin) associated…

  14. Artikel Jurnal

    Improving olaparib exposure to optimize adverse effects management

    Marylise Sterlé; Alicja Puszkiel; Chloé Burlot dkk.

    Therapeutic Advances in Medical Oncology, Vol. 16 · 2024 · Inggris · DOAJ Scopus

    Background: Olaparib is an inhibitor of the human poly-(ADP-ribose)-polymerase enzymes (PARP1/2) needed to repair single-strand DNA breaks. It is used in breast, ovarian, prostate and pancreatic cancer. Objectives: This work aimed to describe the pharmacokinetics/pharmacodynamics (PK/PD)…

  15. Artikel Jurnal Teks lengkap

    Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study

    Maud Velev; Alicja Puszkiel; Benoit Blanchet dkk.

    Pharmaceuticals, Vol. 14 No. 8 · 2021 · Inggris · DOAJ Scopus

    Factors associated with olaparib toxicity remain unknown in ovarian cancer patients. The large inter-individual variability in olaparib pharmacokinetics could contribute to the onset of early significant adverse events (SAE). We aimed to retrospectively analyze the pharmacokinetic/pharmacodynamic…